赵学飞,梁琦,雷新军

• 1:西安交通大学第一附属医院心内科
• 2:陕西中医药大学第二附属医院心内科

摘要(Abstract)：

<正>1临床资料患者男,59岁,于2019年7月30日因"发作性胸闷、气短4年,加重10 d"入住西安交通大学第一附属医院。4年前常于快步行走或重体力活动时感到胸闷、气短,无明显胸痛,休息5～6 min后自行缓解,曾在当地医院按"冠心病"诊治,效果不佳。入院前10 d劳动过程中突感胸骨后闷痛,范围约手掌大小,伴心慌、气短和全身冷汗,当地医院急诊冠状动脉造影(coronary angiography,CAG)示:冠状动脉

关键词(KeyWords)： 梅毒性主动脉炎;冠状动脉左主干病变;冠状动脉穿孔;经皮冠状动脉介入治疗

Abstract:

Keywords:

基金项目(Foundation): 陕西省重点研发计划一般项目(2018SF-079)

作者(Author): 赵学飞,梁琦,雷新军

参考文献(References)：

• [1]Jadeed R,Paarmann R,Harringer W,et al.Syphilitic aortitis presenting with coronary ostial stenosis and aortic regurgitation.J Heart Valve Dis,2016,25(1):18-20.
• [2]Fernandes B,Santos A,Carvalho L.Syphilitic aortitis diagnosis in clinical setting.Rev Port Cir Cardiotorac Vasc.2017,24(3-4):166.
• [3]Barbosa-Barros R,Pérez-Riera AR,Koivula K,et al.Acute coronary syndrome of very unusual etiology.Ann Noninvasive Electrocardiol,2018,23(5):e12531.
• [4]中国疾病预防控制中心性病控制中心.梅毒、淋病、生殖器疱疹、生殖道沙眼衣原体感染诊疗指南（2014）.中华皮肤科杂志，2014,47(5):365-372.
• [5]Treacy AD,Norita K,Ingram PJ,et al.Pseudotumour formation in atheromatous coronary arteries.J Forensic Leg Med,2015,32:73-76.
• [6]朱晓多，许超蕊，杨兆颖，等.梅毒性心血管病的临床治疗.中国医药指南，2013,11(8):67-69.
• [7]?virblyt?R,Ereminien?E,Montvilait?A,et al.Syphilitic coronary artery ostial stenosis resulting in acute myocardial infarction.Medicina(Kaunas),2017,53(3):211-216.
• [8]王茜，张素娟，宋毓青，等.冠心病合并梅毒患者临床特征分析.中国医学前沿杂志（电子版），2018,10(8):46-49.
• [9]Valgimigli M,Bueno H,Byrne RA,et al.2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS:The Task Force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology(ESC)and of the European Association for CardioThoracic Surgery(EACTS).Eur Heart J,2018,39(3):213-260.
• [10]Knuuti J,Wijns W,Saraste A,et al.2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes.Eur Heart J,2020,41(3):407-477.
• [11]Windecker S,Kolh P,Alfonso F,et al.2014 ESC/EACTS Guidelines on myocardial revascularization:The Task Force on Myocardial Revascularization of the European Society of Cardiology(ESC)and the European Association for Cardio-Thoracic Surgery(EACTS)Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions(EAPCI).Eur Heart J,2014,35(37):2541-2619.
• [12]Neumann FJ,Sousa-Uva M,Ahlsson A,et al.2018 ESC/EACTSGuidelines on myocardial revascularization.Euro Intervention,2019,14(14):1435-1534.
• [13]Predescu LM,Zarma L,Platon P,et al.ST segment elevation myocardial infarction due to severe ostial left main stem stenosis in a patient with syphilitic aortitis.Rom J Intern Med,2016,54(1):74-79.
• [14]Kirtane AJ,Doshi D,Leon MB,et al.Treatment of higher-risk patients with an indication for revascularization:evolution within the field of contemporary percutaneous coronary intervention.Circulation,2016,134(5):422-431.
• [15]Werner N,Nickenig G,Sinning JM.Complex PCI procedures:challenges for the interventional cardiologist.Clin Res Cardiol,2018,107(Suppl 2):64-73.
• [16]冷文修，高立建，杨跃进.典型复杂高危有经皮冠状动脉介入治疗适应证患者1例处理策略.中国介入心脏病学杂志，2020,28(1):50-51.
• [17]高好考，陈根锐，程亮，等.体外膜肺氧合联合主动脉内球囊反搏在高危经皮冠状动脉介入治疗中的应用.中国介入心脏病学杂志，2019,27(8):433-439.
• [18]Perera D,Stables R,Thomas M,et al.BCIS-1 Investigators.Elective intra-aortic balloon counterpulsation during high-risk percutaneous coronary intervention:a randomized controlled trial.JAMA,2010,304(8):867-874.
• [19]Shimony A,Joseph L,Mottillo S,et al.Coronary artery perforation during percutaneous coronary intervention:a systematic review and meta-analysis.Can J Cardiol,2011,27(6):843-850.
• [20]雷新军.冠状动脉穿孔的急诊处理策略.中国介入心脏病学杂志2012,20(Suppl 2):11-16.
• [21]Xenogiannis I,Brilakis ES.Advances in the treatment of coronary perforations.Catheter Cardiovasc Interv,2019,93(5):921-922.
• [22]Wang X,Ge J.Balloon occlusion types in the treatment of coronary perforation during percutaneous coronary intervention.Cardiol Res Pract,2014,2014:784018.